INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 38 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $107,555,623 | +9.5% | 108,858,000 | +5.5% | 2.37% | +13.1% |
Q2 2023 | $98,192,736 | +4.0% | 103,200,000 | 0.0% | 2.10% | -0.4% |
Q1 2023 | $94,378,258 | -1.5% | 103,200,000 | +0.5% | 2.10% | +6.1% |
Q4 2022 | $95,820,127 | +30.9% | 102,700,000 | +36.9% | 1.98% | +36.1% |
Q3 2022 | $73,212,000 | +3.9% | 75,000,000 | 0.0% | 1.46% | +0.3% |
Q2 2022 | $70,460,000 | -6.0% | 75,000,000 | 0.0% | 1.45% | -13.3% |
Q1 2022 | $74,929,000 | +46.0% | 75,000,000 | +50.0% | 1.68% | +55.7% |
Q4 2021 | $51,321,000 | -0.8% | 50,000,000 | 0.0% | 1.08% | +6.6% |
Q3 2021 | $51,712,000 | -1.5% | 50,000,000 | 0.0% | 1.01% | +8.1% |
Q2 2021 | $52,525,000 | -22.7% | 50,000,000 | -18.0% | 0.93% | -34.7% |
Q1 2021 | $67,986,000 | -1.8% | 61,000,000 | 0.0% | 1.43% | +4.5% |
Q4 2020 | $69,219,000 | +4.9% | 61,000,000 | 0.0% | 1.37% | -14.9% |
Q3 2020 | $65,987,000 | +11.2% | 61,000,000 | 0.0% | 1.61% | -7.0% |
Q2 2020 | $59,326,000 | +16.5% | 61,000,000 | 0.0% | 1.73% | +6.9% |
Q1 2020 | $50,928,000 | – | 61,000,000 | – | 1.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |